Glippy vs DoseMate
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Glippy
Manage your GLP-1 medication journey with this free app. Track injections, daily health metrics like weight and water intake, and monitor side effects. Connect with a supportive community and visualize your progress with clear data exports.
- Effortless shot tracking
- Daily health check-ins
- Supportive community forum
- Clear progress visuals
- Easy data export (PDF/CSV)
- Privacy-focused design
Read full descriptionHide full description
No paywalls. No subscriptions. Just Glippy — your GLP-1 journey, completely free. Take control of your GLP-1 journey with Glippy, the completely free all-in-one app for Ozempic®, Mounjaro®, Wegovy®, and Zepbound® and compound semaglutide and tirzepatide medications. Why Glippy? EFFORTLESS SHOT TRACKING: Log weekly injections in seconds. Use the daily check-in to record weight, calories, protein, water, and side effects. SUPPORTIVE COMMUNITY You're not alone. Ask questions, share wins, and learn from others on the same path. CLEAR VISUALS Understand your trends at a glance. Connect side effects with shot days and monitor progress over time. EASY DATA EXPORT Your data is yours. Export shots, weight, and side effects to PDF or CSV. BUILT FOR PRIVACY No name, address, or phone required. Email is only needed if you want account recovery. Health Disclaimer Glippy is designed for tracking, discussions, and educational purposes only. It is not intended to provide any medical guidance or advice. Always consult with your healthcare provider for any medical decisions or health concerns. Privacy Policy: https://glippy.app/privacy-policy/ Terms of Use: https://glippy.app/terms-of-service/
DoseMate
This app helps users track their GLP-1 medication progress, including shots, side effects, weight, and blood glucose. It offers calorie deficit management and detailed analytics with Apple Health integration.
- Shot logging and medication history
- Side effect monitoring
- Weight and blood glucose tracking
- Calorie deficit management
- Detailed progress analytics
- Apple Health integration
Read full descriptionHide full description
DoseMate is tracking tool designed for users of GLP-1 medications like Ozempic, Mounjaro, Wegovy, and Zepbound. With the help of DoseMate, you can set weight loss or blood glucose lowering goals and track the progress. SHOT TRACKING: Log your shots and keep track of your medication history. Record and monitor your side effects, weight, blood glucose, calories. CALORIE DEFICIT MANAGEMENT：Track your daily calorie intake and expenditure to ensure your calorie deficit is sufficient to meet your weight loss or blood glucose control goals. DETAILED ANALYTICS: Gain valuable insights into your progress with detailed charts and visualizations. Understand your trends and adjust your goals as needed. APPLE HEALTH INTEGRATION: Automatically import your weight, blood glucose, calories data from Apple Health for a more comprehensive view of your progress. Privacy Policy: https://dosemateterms.onspace.app/ Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Screenshots
Verdict
The clearest difference is rating: Glippy at 4.8 against DoseMate's 3.0. Glippy also leads on in-app purchases (none vs 3) and ratings volume (462 vs 16). DoseMate's advantage is update cadence (every 6 days vs monthly). On price, ads, monetization model and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. DoseMate sells 3 in-app purchases, starting at $6.99 per month. Glippy asks for nothing beyond the download.
Glippy holds the better App Store score, 4.8 against 3.0. That said, the two scores are not equally well evidenced: Glippy has 462 ratings behind it against 16, so its average is the more settled of the two. Written reviews point the same way: 100% of Glippy's written reviews are positive against 83% of DoseMate's.
Glippy ships an update monthly, DoseMate every 6 days. The most recent releases landed on October 30, 2026 and October 24, 2026 respectively.
| Parameter | Glippy | DoseMate |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (462 ratings) — better | 3.0 (16 ratings) |
| Positive reviews | 100.0% of reviews — better | 83.3% of reviews |
| Number of ratings | 462 — better | 16 |
| Update frequency | Monthly | Every 6 days — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free with in-app purchases | Free with in-app purchases |
| Devices | iPhone | iPhone, iPad — better |
| Requires iOS | 16.4 — better | 16.6 |
| Further details — not scored | ||
| Size | 80 MB | 42 MB |
| Age rating | 17+ | 4+ |
| Developer | Glippy LLC | SoulZ AI Inc. |
Customer experience
Glippy
DoseMate
In-app purchases
Glippy
No in-app purchases
DoseMate
- month7 Days trial$6.991 Month
- week3 Days trial$6.997 Days
- year3 Days trial$79.991 Year
